{
  "catalogId": "bb96d973-6790-4f07-97af-fad6dd94b1a9",
  "name": "IBRANCE TABLETS 100 MG",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "173 62 36956 99",
  "treatmentDescriptions": "IIBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:* an aromatase inhibitor as initial endocrine-based therapy; or* fulvestrant in patients with disease progression following endocrine therapy.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "PALBOCICLIB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE33",
      "name": "PALBOCICLIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "IBRANCE 125 MG 21 CAPS",
      "manufacturer": {
        "name": "פיזר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 21.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/OPA/AL",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7908",
        "yarpa": "56882",
        "pharmasoft": "9956",
        "barcode": "5415062107560"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 7395.106767,
        "retailMargin": 10.0,
        "maxRetailPrice": 8134.617443,
        "maxPriceWithVAT": 9598.848156
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T03:55:32.772520"
  }
}